What Analysts Are Saying About CVS Health Stock
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings on CVS Health (NYSE:CVS) over the past three months, with most maintaining a neutral stance. The average 12-month price target is $62.27, with a slight decrease in sentiment. CVS Health's financial metrics show strong profitability and effective asset utilization, but revenue growth lags behind industry peers.
October 01, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
CVS Health has received mixed analyst ratings, with a predominant neutral stance. The average price target is $62.27, indicating a slight decrease in sentiment. Financial metrics show strong profitability but lagging revenue growth compared to peers.
The majority of analysts maintain a neutral rating on CVS Health, with a slight decrease in the average price target, indicating stable but cautious sentiment. Financial metrics show strong profitability, but revenue growth is slower than peers, which may concern investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100